Balyasny Asset Management
RMTI icon

Balyasny Asset Management’s Rockwell Medical RMTI Stock Holding History

Balyasny Asset Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-276
Closed -$351K – 1297
2015
Q1 		$332K Buy
+276
New +$323K ﹤0.01% 766

Other funds holding RMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Balyasny Asset Management's RMTI Position: Q2 2015 in Review

Balyasny Asset Management sold out of Rockwell Medical (RMTI) in Q2 2015, closing a stake of 276 shares — an estimated $351K sold.

Balyasny Asset Management first reported a position in RMTI in Q1 2015 and held it in 1 quarter. The position peaked at $332K in Q1 2015. 99 funds tracked by Wall St. Rank hold RMTI as of Q2 2015.

  • Balyasny Asset Management reported no remaining Rockwell Medical position as of Q2 2015 after selling out during the quarter.
  • Balyasny Asset Management sold 276 Rockwell Medical shares in Q2 2015, an estimated $351K.
  • Balyasny Asset Management first reported a position in Rockwell Medical in Q1 2015 and held it in 1 quarter.
  • Balyasny Asset Management's Rockwell Medical position peaked at $332K in Q1 2015.
  • 99 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2015.

Based on Balyasny Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.